APA
Dufort G., Castillo L., Pisano S., Castiglioni M., Carolina P., Andrea I., Simon E., Zuccolo S., Schelotto M., Morosini F., Pereira I., Amarillo P., Silveira A., Guerrero L., Ferreira V., Tiscornia A., Mezzano R., Lemos F., Boggia B., Quarnetti A., Decaro J. & Dabezies A. (20171212). Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center. : Bone marrow transplantation.
Chicago
Dufort G, Castillo L, Pisano S, Castiglioni M, Carolina P, Andrea I, Simon E, Zuccolo S, Schelotto M, Morosini F, Pereira I, Amarillo P, Silveira A, Guerrero L, Ferreira V, Tiscornia A, Mezzano R, Lemos F, Boggia B, Quarnetti A, Decaro J and Dabezies A. 20171212. Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center. : Bone marrow transplantation.
Harvard
Dufort G., Castillo L., Pisano S., Castiglioni M., Carolina P., Andrea I., Simon E., Zuccolo S., Schelotto M., Morosini F., Pereira I., Amarillo P., Silveira A., Guerrero L., Ferreira V., Tiscornia A., Mezzano R., Lemos F., Boggia B., Quarnetti A., Decaro J. and Dabezies A. (20171212). Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center. : Bone marrow transplantation.
MLA
Dufort G, Castillo L, Pisano S, Castiglioni M, Carolina P, Andrea I, Simon E, Zuccolo S, Schelotto M, Morosini F, Pereira I, Amarillo P, Silveira A, Guerrero L, Ferreira V, Tiscornia A, Mezzano R, Lemos F, Boggia B, Quarnetti A, Decaro J and Dabezies A. Haploidentical hematopoietic stem cell transplantation in children with high-risk hematologic malignancies: outcomes with two different strategies for GvHD prevention. Ex vivo T-cell depletion and post-transplant cyclophosphamide: 10 years of experience at a single center. : Bone marrow transplantation. 20171212.